Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer's disease.
Saved in:
| Title: | Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer's disease. |
|---|---|
| Authors: | Kara B; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA., Kelly IM; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA., Beck JS; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA., Kuhn N; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA., Mufson EJ; Department of Translational Neuroscience, Barrow Neurological Institute, Phoenix, AZ 85013 USA., Vega IE; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA., Kanaan NM; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA., Counts SE; Department of Translational Neuroscience, Michigan State University, 400 Monroe Ave NW, Grand Rapids, MI 49503 USA.; Cell and Molecular Biology Program, Michigan State University, East Lansing, MI 48824 USA.; Michigan Alzheimer's Disease Research Center, Ann Arbor, MI 48109 USA.; Department of Family Medicine, Michigan State University, East Lansing, MI 48824 USA.; Trinity Health Hauenstein Neurosciences Center, Grand Rapids, MI 49503 USA. |
| Source: | Molecular neurodegeneration advances [Mol Neurodegener Adv] 2026; Vol. 2 (1), pp. 13. Date of Electronic Publication: 2026 Jan 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9919054337306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 3059-4944 (Electronic) Linking ISSN: 30594944 NLM ISO Abbreviation: Mol Neurodegener Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
